Free Trial

NRx Pharmaceuticals (NRXP) Earnings Date, Estimates & Call Transcripts

NRx Pharmaceuticals logo
$2.59 +0.01 (+0.39%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$2.58 0.00 (-0.19%)
As of 05:45 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NRx Pharmaceuticals Earnings Summary

NRx Pharmaceuticals posted Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.34, which topped analysts' consensus estimates of -$0.40 by $0.06. Quarterly revenue was reported to be $1.14 million, below analyst estimates of $1.14 million. With a trailing EPS of -$2.01, NRx Pharmaceuticals' earnings are expected to grow next year, from ($1.75) to ($0.08) per share.

Upcoming Q2
Earnings Date
Aug. 13After Market ClosesEstimated
Consensus EPS
(May. 15)
-$0.40
Actual EPS
(May. 15)
-$0.34 Beat By $0.06
Actual Revenue
(May. 15)
$1.14M

Q1 2025 Earnings Resources

NRXP Upcoming Earnings

NRx Pharmaceuticals' next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules.

Get NRx Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NRx Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NRXP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NRx Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate
($1.75) EPS
Next Year EPS Consensus Estimate
($0.08) EPS

NRx Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/13/2025
(Estimated)
--------
5/15/2025Q1 2025-$0.40-$0.34+$0.06-$0.34$1.14M$1.14M
3/14/2025Q4 2024-$0.20-$0.30 -$0.10-$0.77--
8/14/2024Q2 2024-$0.81-$0.75+$0.06-$0.75--
5/14/2024Q1 2024--$0.74 -$0.74-$0.74--
3/29/2024Q4 2023--$0.50 -$0.50-$0.50--
11/13/2023Q3 2023-$11.00-$7.00+$4.00-$0.07--
8/14/2023Q2 2023-$14.00-$12.00+$2.00-$0.12--

NRx Pharmaceuticals Earnings - Frequently Asked Questions

NRx Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on NRXP's earnings history.

In the previous quarter, NRx Pharmaceuticals (NASDAQ:NRXP) reported ($0.34) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.40) by $0.06. Learn more on analysts' earnings estimate vs. NRXP's actual earnings.

The conference call for NRx Pharmaceuticals's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for NRx Pharmaceuticals's latest earnings report can be read online.
Read Transcript

NRx Pharmaceuticals (NASDAQ:NRXP) has a recorded net income of -$30.15 million. NRXP has generated -$2.01 earnings per share over the last four quarters.

NRx Pharmaceuticals's earnings are expected to grow from ($1.75) per share to ($0.08) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:NRXP) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners